{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T16:00:39Z","timestamp":1768147239172,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.anndiagpath.2015.04.006","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T16:42:32Z","timestamp":1430930552000},"page":"216-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems"],"prefix":"10.1016","volume":"19","author":[{"given":"Ann E.","family":"Walts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto M.","family":"Marchevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0005","series-title":"Pathology of the mediastinum","author":"Marchevsky","year":"2014"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0155","series-title":"World Health Organization classification of tumors","first-page":"146","article-title":"Tumors of the thymus","author":"Muller-Hermelink","year":"2004"},{"issue":"7 Suppl. 3","key":"10.1016\/j.anndiagpath.2015.04.006_bb0015","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.semdp.2006.02.004","article-title":"Problem areas and inconsistencies in the WHO classification of thymoma","volume":"22","author":"Suster","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1309\/2GAYKPDDM85P2VEW","article-title":"Expression of p63 in thymomas and normal thymus","volume":"127","author":"Dotto","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0030","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.144.5.1783","article-title":"Tumor necrosis factor-alpha and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2","volume":"144","author":"Suda","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"p40 is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"Bishop","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0040","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.5858\/arpa.2012-0635-OA","article-title":"Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung","volume":"137","author":"Brown","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345245","article-title":"P40: a p63 isoform useful for lung cancer diagnosis\u2014a review of the physiological and pathological role of p63","volume":"57","author":"Nobre","year":"2013","journal-title":"Acta Cytol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0050","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.5858\/arpa.2013-0342-OA","article-title":"An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers","volume":"138","author":"Tacha","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAI.0b013e3182980544","article-title":"p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, cytokeratin 5\/6, desmocollin-3, and sox2","volume":"22","author":"Tatsumori","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-003-0857-4","article-title":"Constitutive expression of \u2206N-p63a isoform in human thymus and thymic epithelial tumors","volume":"443","author":"Chilosi","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/PAI.0b013e318245c730","article-title":"Desmoglein-3 and napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes","volume":"20","author":"Agackiran","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0070","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/jclinpath-2011-200630","article-title":"Diagnostic and prognostic impact of desmocollins in human lung cancer","volume":"65","author":"Cui","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/his.12126","article-title":"Differential immunohistochemical localization of desmosomal plaque-related proteins in non-small-cell lung cancer","volume":"63","author":"Gomez-Morales","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.prp.2014.10.008","article-title":"Expression of desmogleins 1-3 and their clinical impacts on human lung cancer","volume":"211","author":"Saaber","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0085","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2353\/ajpath.2009.080778","article-title":"The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung","volume":"174","author":"Savci-Heijink","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAI.0b013e31823d7f0e","article-title":"A six antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma","volume":"20","author":"Tacha","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0095","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/ejcts\/ezs529","article-title":"Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies","volume":"43","author":"Roden","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.53.9","article-title":"The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma","volume":"53","author":"Hayashi","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/jid.2010.330","article-title":"Aire-dependent thymic expression of desmoglein-3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance","volume":"131","author":"Wada","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1399-0039.2008.01020.x","article-title":"Expression of pemphigus-autoantigen desmoglein 1 in human thymus","volume":"71","author":"Mouquet","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","article-title":"Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining","volume":"117","author":"Beutner","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1523-1747.ep12340663","article-title":"Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies","volume":"106","author":"Memar","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/00015555-2023","article-title":"et al. Autoantibody levels and clinical disease severity in patients with pemphigus: comparison of aggregated anti-desmoglein ELISA values and indirect immunofluorescence titres","volume":"95","author":"Weiss","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7819-6-83","article-title":"Paraneoplastic pemphigus regression after thymoma resection","volume":"6","author":"Barbetakis","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0135","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00595-012-0272-z","article-title":"Pemphigus with thymoma improved by thymectomy: report of a case","volume":"43","author":"Yoshida","year":"2013","journal-title":"Surg Today"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2005.06599.x","article-title":"Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus","volume":"153","author":"Wang","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2169\/internalmedicine.39.742","article-title":"Thymoma with pemphigus foliaceus","volume":"39","author":"Takeshita","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.anndiagpath.2015.04.006_bb0150","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/onc.2013.186","article-title":"Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation","volume":"33","author":"Brown","year":"2014","journal-title":"Oncogene"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913415000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913415000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T04:25:08Z","timestamp":1691641508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913415000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1092913415000751"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2015.04.006","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2015.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}